Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Allogenic umbilical cord blood therapy combined with erythropoietin for patients with severe traumatic brain injury: three case reports.

Min K, Song J, Lee JH, Kang MS, Jang SJ, Kim SH, Kim M.

Restor Neurol Neurosci. 2013;31(4):397-410. doi: 10.3233/RNN-120289.

PMID:
23515110
2.

Umbilical cord blood therapy potentiated with erythropoietin for children with cerebral palsy: a double-blind, randomized, placebo-controlled trial.

Min K, Song J, Kang JY, Ko J, Ryu JS, Kang MS, Jang SJ, Kim SH, Oh D, Kim MK, Kim SS, Kim M.

Stem Cells. 2013 Mar;31(3):581-91. doi: 10.1002/stem.1304.

3.

Umbilical cord mesenchymal stem cell transplantation significantly improves neurological function in patients with sequelae of traumatic brain injury.

Wang S, Cheng H, Dai G, Wang X, Hua R, Liu X, Wang P, Chen G, Yue W, An Y.

Brain Res. 2013 Sep 26;1532:76-84. doi: 10.1016/j.brainres.2013.08.001.

PMID:
23942181
4.

Safety and efficacy of recombinant human erythropoietin treatment of non-motor symptoms in Parkinson's disease.

Jang W, Park J, Shin KJ, Kim JS, Kim JS, Youn J, Cho JW, Oh E, Ahn JY, Oh KW, Kim HT.

J Neurol Sci. 2014 Feb 15;337(1-2):47-54. doi: 10.1016/j.jns.2013.11.015.

PMID:
24289887
5.

Synergistic benefits of erythropoietin and simvastatin after traumatic brain injury.

Chauhan NB, Gatto R.

Brain Res. 2010 Nov 11;1360:177-92. doi: 10.1016/j.brainres.2010.09.010.

PMID:
20833152
6.

Anti-edema effects of rhEpo in experimental traumatic brain injury.

Gatto R, Chauhan M, Chauhan N.

Restor Neurol Neurosci. 2015;33(6):927-41. doi: 10.3233/RNN-150577.

PMID:
26484701
8.

Effects of erythropoietin on reducing brain damage and improving functional outcome after traumatic brain injury in mice.

Xiong Y, Lu D, Qu C, Goussev A, Schallert T, Mahmood A, Chopp M.

J Neurosurg. 2008 Sep;109(3):510-21. doi: 10.3171/JNS/2008/109/9/0510.

9.

[Usefulness of FDG-PET in the diagnosis of patients with chronic severe brain injury].

de la Cueva L, Noé E, López-Aznar D, Ferri J, Sopena R, Martínez C, Chirivella J, Abreu P, Uruburu E.

Rev Esp Med Nucl. 2006 Mar-Apr;25(2):89-97. Spanish.

10.

Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial.

Nichol A, French C, Little L, Haddad S, Presneill J, Arabi Y, Bailey M, Cooper DJ, Duranteau J, Huet O, Mak A, McArthur C, Pettilä V, Skrifvars M, Vallance S, Varma D, Wills J, Bellomo R; EPO-TBI Investigators.; ANZICS Clinical Trials Group..

Lancet. 2015 Dec 19;386(10012):2499-506. doi: 10.1016/S0140-6736(15)00386-4.

PMID:
26452709
11.

Reduced brain edema and functional deficits after treatment of diffuse traumatic brain injury by carbamylated erythropoietin derivative.

Bouzat P, Francony G, Thomas S, Valable S, Mauconduit F, Fevre MC, Barbier EL, Bernaudin M, Lahrech H, Payen JF.

Crit Care Med. 2011 Sep;39(9):2099-105. doi: 10.1097/CCM.0b013e31821cb7b2.

PMID:
21552121
12.

High-definition fiber tracking for assessment of neurological deficit in a case of traumatic brain injury: finding, visualizing, and interpreting small sites of damage.

Shin SS, Verstynen T, Pathak S, Jarbo K, Hricik AJ, Maserati M, Beers SR, Puccio AM, Boada FE, Okonkwo DO, Schneider W.

J Neurosurg. 2012 May;116(5):1062-9. doi: 10.3171/2012.1.JNS111282.

PMID:
22381003
13.

Classification of cause of motor weakness in traumatic brain injury using diffusion tensor imaging.

Choi GS, Kim OL, Kim SH, Ahn SH, Cho YW, Son SM, Jang SH.

Arch Neurol. 2012 Mar;69(3):363-7. doi: 10.1001/archneurol.2011.1930.

PMID:
22083801
14.

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology.; Technology Assessment Committee of the Society of Interventional Radiology..

Stroke. 2003 Aug;34(8):e109-37. Erratum in: Stroke. 2003 Nov;34(11):2774.

15.

Can we improve neurological outcomes in severe traumatic brain injury? Something old (early prophylactic hypothermia) and something new (erythropoietin).

Nichol AD, Cooper DJ; POLAR Study Investigators on behalf of the ANZICS-Clinical Trials Group.; EPO Study Investigators on behalf of the ANZICS-Clinical Trials Group..

Injury. 2009 May;40(5):471-8. doi: 10.1016/j.injury.2009.01.002. Review.

PMID:
19371869
16.

Involvement of Immune Responses in the Efficacy of Cord Blood Cell Therapy for Cerebral Palsy.

Kang M, Min K, Jang J, Kim SC, Kang MS, Jang SJ, Lee JY, Kim SH, Kim MK, An SA, Kim M.

Stem Cells Dev. 2015 Oct 1;24(19):2259-68. doi: 10.1089/scd.2015.0074.

PMID:
25977995
17.
18.

Role of gender in outcome after traumatic brain injury and therapeutic effect of erythropoietin in mice.

Xiong Y, Mahmood A, Lu D, Qu C, Goussev A, Schallert T, Chopp M.

Brain Res. 2007 Dec 14;1185:301-12.

19.

Combination therapy of human umbilical cord blood cells and granulocyte colony stimulating factor reduces histopathological and motor impairments in an experimental model of chronic traumatic brain injury.

Acosta SA, Tajiri N, Shinozuka K, Ishikawa H, Sanberg PR, Sanchez-Ramos J, Song S, Kaneko Y, Borlongan CV.

PLoS One. 2014 Mar 12;9(3):e90953. doi: 10.1371/journal.pone.0090953.

20.

Diffusion tensor imaging in relation to cognitive and functional outcome of traumatic brain injury in children.

Levin HS, Wilde EA, Chu Z, Yallampalli R, Hanten GR, Li X, Chia J, Vasquez AC, Hunter JV.

J Head Trauma Rehabil. 2008 Jul-Aug;23(4):197-208. doi: 10.1097/01.HTR.0000327252.54128.7c.

Items per page

Supplemental Content

Support Center